Decision aid for parents of infants with kidney obstruction
Pilot-testing of a Decision Aid for Parents of Infants With Ureteropelvic Junction Obstruction (UPJO)
This study is testing a decision aid to help parents of young children with kidney obstruction understand their treatment options and make informed choices about surgery or observation.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years to 89 Years |
| Sex | All |
| Sponsor | University of Colorado, Denver Academic / other |
| Locations | 1 site (Aurora, Colorado) |
| Trial ID | NCT05900375 on ClinicalTrials.gov |
What this trial studies
This study aims to provide a decision aid for parents of infants diagnosed with ureteropelvic junction obstruction (UPJO), a condition that can lead to significant kidney damage if not treated appropriately. The intervention focuses on shared decision-making to help parents understand the risks and benefits of early surgical intervention versus observation. By addressing the uncertainties surrounding treatment options, the study seeks to standardize care and improve outcomes for infants with high-grade hydronephrosis. The trial will involve parents of children aged 30 days to 2 years who are consulting for this condition at Children's Hospital Colorado.
Who should consider this trial
Good fit: Ideal candidates are parents of infants aged 30 days to 2 years presenting with high-grade hydronephrosis at Children's Hospital Colorado.
Not a fit: Patients who do not have a child diagnosed with UPJO or who fall outside the specified age range will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could empower parents to make informed decisions regarding their child's treatment, potentially improving kidney health outcomes.
How similar studies have performed: While the approach of using decision aids in medical contexts is gaining traction, this specific application for UPJO in infants is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria (all of following are needed): * parents (age 18-89 years) of children age 30 days - 2 years * child is presenting for consultation for SFU grade 3-4 Hydronephrosis at Children's Hospital Colorado * parents/child presenting at Urology appointment where a MAG 3 is performed or has recently been performed. Exclusion Criteria: * does not meet age parameters * does not have a child with a UPJO
Where this trial is running
Aurora, Colorado
- Children's Hospital Colorado — Aurora, Colorado, United States (Recruiting)
Study contacts
- Principal investigator: Vijaya Vemulakonda, MD, JD — Children's Hospital Colorado
- Study coordinator: Alison Saville, MSPH, MSW
- Email: alison.saville@cuanschutz.edu
- Phone: 7202574406
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.